Notification of cessation of securities - PER

Aug 31, 2026 at 3:01 AM EDT · Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · Aug 31, 2026 at 3:01 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-per

Release

Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 1 / 4 Announcement Summary Entity name PERCHERON THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Monday August 31, 2026 Details of +securities that...

Percheron Therapeutics Limited on 6ix

In the deck

Percheron Therapeutics — Investor Presentation (September 2026)14 slidesSep 1, 2026

Earlier from Percheron Therapeutics

Percheron receives $0.70m R&D Tax Incentive RebateAug 30
Trading HaltAug 27
Vanderbilt Health to conduct clinical trial of HMBD-002Aug 27
Appendix 4E and Annual ReportAug 19
Appendix 4G and Corporate Governance StatementAug 18

Later from Percheron Therapeutics

Change of Director's Interest NoticeAug 31
Transitional appointment of Executive DirectorAug 31
Initial Director's Interest NoticeAug 31
Proposed issue of securities - PERAug 31
Percheron raises $2.3m to fully fund clinical trial in AMLAug 31

All Percheron Therapeutics news releases

Follow Percheron Therapeutics into a list and get an email when it puts out news.

Follow Percheron Therapeutics